共 25 条
- [1] OPTIMAL DOSAGE REGIMENS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR[J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (02) : 160 - 162AGNELLI, GHIRSH, J
- [2] A COMPARISON OF THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND STREPTOKINASE IN RABBITS[J]. CIRCULATION, 1985, 72 (01) : 178 - 182AGNELLI, GBUCHANAN, MRFERNANDEZ, FBONEU, BVANRYN, JHIRSH, JCOLLEN, D
- [3] THE THROMBOLYTIC AND HEMORRHAGIC EFFECTS OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR - INFLUENCE OF DOSAGE REGIMENS IN RABBITS[J]. THROMBOSIS RESEARCH, 1985, 40 (06) : 769 - 777AGNELLI, GBUCHANAN, MRFERNANDEZ, FHIRSH, J
- [4] AGNELLI G, 1985, BLOOD, V66, P399
- [5] INCREASED SERUM LEVELS OF FIBRINOGEN DEGRADATION PRODUCTS DUE TO TREATMENT WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION ARE RELATED TO BLEEDING COMPLICATIONS, BUT NOT TO CORONARY PATENCY[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (03) : 581 - 588ARNOLD, AERBROWER, RWCOLLEN, DVANES, GALUBSEN, JSERRUYS, PWSIMOONS, MLVERSTRAETE, M
- [6] BOLUS DOSE-RESPONSE CHARACTERISTICS OF SINGLE CHAIN UROKINASE PLASMINOGEN-ACTIVATOR AND TISSUE PLASMINOGEN-ACTIVATOR IN A DOG-MODEL OF ARTERIAL THROMBOSIS[J]. THROMBOSIS RESEARCH, 1988, 52 (04) : 295 - 312BADYLAK, SFVOYTIK, SKLABUNDE, REHENKIN, JLESKI, M
- [7] BRUNNING JL, 1977, COMPUTATIONAL HDB ST, P18
- [8] TIME COURSE OF THROMBOLYSIS INDUCED BY INTRAVENOUS BOLUS OR INFUSION OF TISSUE PLASMINOGEN-ACTIVATOR IN A RABBIT JUGULAR VEIN-THROMBOSIS MODEL[J]. CIRCULATION, 1989, 79 (01) : 125 - 133CLOZEL, JPTSCHOPP, TLUEDIN, EHOLVOET, P
- [9] COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77
- [10] Colton T., 1974, STAT MED, P151